FR2968169A1 - Biological response modifying nutritional supplement, comprises marine aragonite microgranules coated with a freeze-dried jelly of Lycium barbarum or Lycium chinense berry - Google Patents
Biological response modifying nutritional supplement, comprises marine aragonite microgranules coated with a freeze-dried jelly of Lycium barbarum or Lycium chinense berry Download PDFInfo
- Publication number
- FR2968169A1 FR2968169A1 FR1004775A FR1004775A FR2968169A1 FR 2968169 A1 FR2968169 A1 FR 2968169A1 FR 1004775 A FR1004775 A FR 1004775A FR 1004775 A FR1004775 A FR 1004775A FR 2968169 A1 FR2968169 A1 FR 2968169A1
- Authority
- FR
- France
- Prior art keywords
- lycium
- nutritional supplement
- microgranules
- dried
- berries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 13
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title claims abstract description 12
- 235000015110 jellies Nutrition 0.000 title claims abstract description 9
- 239000008274 jelly Substances 0.000 title claims abstract description 9
- 235000021028 berry Nutrition 0.000 title claims description 16
- 244000241838 Lycium barbarum Species 0.000 title claims description 14
- 235000015459 Lycium barbarum Nutrition 0.000 title claims description 14
- 244000241872 Lycium chinense Species 0.000 title claims description 12
- 235000015468 Lycium chinense Nutrition 0.000 title claims description 12
- 230000008512 biological response Effects 0.000 title abstract 2
- 239000000843 powder Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003607 modifier Substances 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 7
- 239000000047 product Substances 0.000 claims description 7
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 6
- 240000003394 Malpighia glabra Species 0.000 claims description 6
- 235000014837 Malpighia glabra Nutrition 0.000 claims description 6
- 241000237852 Mollusca Species 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 240000002900 Arthrospira platensis Species 0.000 claims description 4
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 4
- 241000340987 Ptychopetalum olacoides Species 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 229940082787 spirulina Drugs 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 4
- 244000163122 Curcuma domestica Species 0.000 claims description 3
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 229960001948 caffeine Drugs 0.000 claims description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 3
- 235000003373 curcuma longa Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 235000009569 green tea Nutrition 0.000 claims description 3
- 239000011859 microparticle Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000013976 turmeric Nutrition 0.000 claims description 3
- 240000006162 Chenopodium quinoa Species 0.000 claims description 2
- 241001490476 Pinctada maxima Species 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 239000007937 lozenge Substances 0.000 claims description 2
- 239000006041 probiotic Substances 0.000 claims description 2
- 235000018291 probiotics Nutrition 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000217407 Margaritifera Species 0.000 claims 1
- 239000005708 Sodium hypochlorite Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000010791 quenching Methods 0.000 claims 1
- 230000000171 quenching effect Effects 0.000 claims 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims 1
- 241001106041 Lycium Species 0.000 abstract 2
- 230000001195 anabolic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000867891 Richeria grandis Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000010982 Lycium chilense Species 0.000 description 2
- 240000003444 Paullinia cupana Species 0.000 description 2
- 235000000556 Paullinia cupana Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- -1 for example Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000037125 natural defense Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241001464019 Pinctada margaritifera Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000002715 bioenergetic effect Effects 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 229910001562 pearlite Inorganic materials 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Complément alimentaire, modificateur de terrain comprenant les microgranules d'aragonite marine enrobés d'une gelée de baies de Lycium barbarum ou chinense Les dysfonctionnements de la plupart des organes et systèmes sont souvent liés à des maladies génétiques et à des agressions microbiennes avec pour corollaire l'absence ou l'insuffisance de production de certaines protéines et d'autres substances qui jouent un rôle essentiel dans le métabolisme cellulaire Dietary supplement, field modifier including marine aragonite microgranules coated with a Lycium barbarum or chinense berries jelly Malfunctions of most organs and systems are often linked to genetic diseases and microbial attacks with the consequent absence or insufficiency of production of certain proteins and other substances which play a key role in cellular metabolism
D'autres dysfonctionnements sont liés à un apport insuffisant d'acides aminés, de protéines, d'oligo éléments et d'autres nutriments indispensables au bon fonctionnement cellulaire et tissulaire. On sait que les baies séchées de Lycium barbarum ou de Lycium chinense contiennent les 19 acides aminés indispensables à la vie et qui interviennent dans la totalité des échanges métaboliques cellulaires - des électrolytes - 21 oligo-éléments dont du cuivre, du zinc, du fer, et surtout du sélénium un antioxydant majeur ainsi que du germanium organique, minéral aux propriétés exceptionnelles dont la fonction principale est l'oxygénation des cellules et un rôle protecteur contre les dysfonctionnements cellulaires ainsi qu'une action inhibitrice sur le développement des bactéries. Elles contiennent en outre, un taux exceptionnel de vitamine C, des vitamines du groupe B dont la B2 et la B3 - de la vitamine E - la plupart des acides gras essentiels polyinsaturés oméga 6 et 3 - des caroténoides, le béta carotène, la lutéine et surtout de la xéaxanthine qui ont un rôle protecteur sur l'ensemble des organes - des polysaccharides qui régulent et stimulent les mécanismes de défense naturelle - des fibres solubles - de la taurine - la bétaine qui joue un rôle dans les défenses naturelles. Other dysfunctions are linked to insufficient intake of amino acids, proteins, trace elements and other nutrients essential for proper cell and tissue function. It is known that the dried berries of Lycium barbarum or Lycium chinense contain the 19 essential amino acids that are involved in all cellular metabolic exchanges - electrolytes - 21 trace elements including copper, zinc, iron, and especially selenium a major antioxidant as well as mineral organic germanium with exceptional properties whose main function is the oxygenation of cells and a protective role against cellular dysfunctions and an inhibitory action on the development of bacteria. They also contain an exceptional level of vitamin C, vitamins of the B group including B2 and B3 - vitamin E - most essential omega 6 and 3 polyunsaturated fatty acids - carotenoids, beta carotene, lutein and especially xeaxanthin that have a protective role on all organs - polysaccharides that regulate and stimulate natural defense mechanisms - soluble fibers - taurine - betaine that plays a role in natural defenses.
On sait également qu'on a isolé de l'aragonite des tests nacrés de certains mollusques bivalves marins, tels que Pinctada Maxima ou Margaritifera - ou le Tridacnae, la plupart des acides aminés majoritaires tels que, entre autres : la valine, la leucine, l'isoleucine, acides aminés essentiels non synthétisés par l'organisme humain - de l'arginine - de l'acide glutamique qui ont des propriétés inhibitrices de radicaux libres - de la glycine qui possède des propriétés antiasthéniques et agit comme tampon biologique et intervient dans le transfert des acides gras. Sont également présents dans l'aragonite la thréonine qui permet au foie de stocker le glycogène qui est une réserve de sucre - la proline qui est un constituant principal du collagène - la tyrosine, amino acide précurseur des mélanines et des catécholamines et qui donne par oxydation la dopa, qui par décarboxilation conduit à la dopamine, neuro- transmetteur jouant un rôle important dans le fonctionnement du cerveau, la tyrosine est aussi un précurseur des hormones thyroïdiennes - la phénylalanine qui est un acide aminé indispensable - l'histidine qui intervient dans de nombreuses réactions biochimiques comme médiateur et donne naissance à l'histamine par décarboxylation - la méthionine qui intervient dans la biosynthèse de nombreuses substances biologiques comme l'adrénaline et qui joue un rôle 1 métabolique indispensable - la cystéine constituant important de la kératine et qui possède des propriétés bioénergétiques - l'alanine qui associée à des protéines ou à l'état libre est présente dans tous les milieux biologiques. L'aragonite contient en outre, de nombreux oligo-élément dont le fer présent dans tous les systèmes métaboliques et dans les enzymes respiratoires - le brome qui possède des propriétés sédatives - le manganèse qui inhibe la libération des médiateurs chimiques impliqués dans les allergies - le sodium qui joue un rôle important dans l'équilibre biologique - le potassium - le soufre, impliqués comme agents biocatalytiques - le zinc constituant des leucocytes, des enzymes et qui joue un rôle important dans la biosynthèse des protéines, dans les processus de reproduction , de la croissance et de la résistance aux infections, l'immuno-stimulation et la production du flux salivaire - le cuivre qui possède des propriétés antibactériennes, antifongiques et anti inflammatoires. La quasi similitude des composants de l'aragonite des tests nacrés de mollusques marins et de ceux contenus dans les baies de Lycium barbarum ou de Lycium chinense, explique l'évidence de l'association synergisante des nutriments de ces éléments afin de disposer d'un puissant actif aux propriétés exponentielles utilisable comme complément nutritif modificateur de terrain. Afin d'accroître les propriétés des actifs contenus dans les baies de Lycium barbarum ou de Lycium chinense et de favoriser leur combinaison avec l'aragonite des tests nacrés des mollusques marins, le demandeur dans un mode de réalisation préférentiel, fait subir aux baies Lycium barbarum ou de Lycium chilense, une série de traitements physiques. It is also known that pearlite tests of some marine bivalve molluscs, such as Pinctada Maxima or Margaritifera - or Tridacnae, most of the major amino acids such as, for example, valine, leucine, have been isolated from aragonite. isoleucine, essential amino acids not synthesized by the human body - arginine - glutamic acid which have free radical-inhibiting properties - glycine which has antiasthenic properties and acts as a biological buffer and is involved in the transfer of fatty acids. Also present in aragonite is threonine, which allows the liver to store glycogen, which is a reserve of sugar - proline, which is a major constituent of collagen - tyrosine, an amino acid precursor to melanins and catecholamines, and which gives by oxidation dopa, which by decarboxilation leads to dopamine, a neurotransmitter that plays an important role in the functioning of the brain, tyrosine is also a precursor of thyroid hormones - phenylalanine, which is an essential amino acid - the histidine which is involved in many biochemical reactions as mediator and gives rise to histamine by decarboxylation - methionine which is involved in the biosynthesis of many biological substances such as adrenaline and which plays an indispensable metabolic role 1 - cysteine important constituent of keratin and which has bioenergetic properties - the alanine that is associated with oteins or in the free state is present in all biological media. Aragonite also contains many trace elements including iron in all metabolic systems and in respiratory enzymes - bromine, which has sedative properties - manganese, which inhibits the release of chemical mediators involved in allergies. sodium which plays an important role in the biological balance - potassium - sulfur, involved as biocatalytic agents - zinc constituting leucocytes, enzymes and which plays an important role in the biosynthesis of proteins, in the processes of reproduction, growth and resistance to infections, immunostimulation and salivary flow production - copper that has antibacterial, antifungal and anti-inflammatory properties. The quasi-similarity of the aragonite components of the pearlescent tests of marine molluscs and those contained in the berries of Lycium barbarum or Lycium chinense, explains the evidence of the synergistic association of the nutrients of these elements in order to have a powerful active with exponential properties that can be used as a nutrient supplement for field modifiers. In order to increase the properties of the active ingredients contained in the berries of Lycium barbarum or Lycium chinense and to promote their combination with the aragonite of the pearlescent tests of marine molluscs, the applicant in a preferred embodiment subjects the berries Lycium barbarum to or Lycium chilense, a series of physical treatments.
C'est ainsi que, selon l'invention les baies de Lycium barbarum ou de Lycium chinense sont broyées dans un broyeur à couteaux de type Blenders d'une contenance de 4,5 litres par exemple jusqu'à l'obtention d'une pâte contenant des particules allant de 1 mm à 300 microns. La pâte ainsi obtenue est placée dans un mélangeur cuiseur cutters sous vide de 50 litres équipé d'une cuve en inox 316L à double paroi permettant le chauffage et le refroidissement, motorisé, muni d'un couvercle équipé de piquages permettant la fixation d'un thermo plongeur, d'un éclairage de cuve, d'un moteur à vitesse variable ; la cuve comportant à sa base un piquage avec vanne de vidange , un dispositif de vide avec pompe et compteur d'eau. Pour un batch de 10 kg de pâte de baies Lycium barbarum ou de Lycium chinense, on ajoute 30 1 d'eau. Le cycle de traitement est ainsi mis en route une fois le vide réalisé pendant une durée de 2 heures à une température interne constante de 40°C. Au terme du cycle de traitement, la purée ainsi obtenue est reprise et soumise à une filtration dans un filtre à bougies sous une pression de 6 bars laissant passer les particules comprises entre 10 et 50 microns. Le filtrat obtenu, de couleur 2 rosée et d'une viscosité de 101Pas à 20°C est brutalement refroidi à 4°C afin de préserver les propriétés organoleptiques des composants. La gelée obtenue est réservée ainsi que le gâteau La gelée contient ainsi toutes les molécules solubles extraites des baies Lycium barbarum ou de Lycium chinense ainsi que les particules végétales d'une dimension de 10 à 50microns. Thus, according to the invention, the berries of Lycium barbarum or Lycium chinense are ground in a Blenders-type knife mill with a capacity of 4.5 liters, for example, until a paste is obtained. containing particles ranging from 1 mm to 300 microns. The dough thus obtained is placed in a 50 liter vacuum cutter cooker mixer equipped with a double wall stainless steel 316L tank for heating and cooling, motorized, provided with a lid equipped with taps for fixing a thermo plunger, tank lighting, variable speed motor; the tank having at its base a stitching with drain valve, a vacuum device with pump and water meter. For a batch of 10 kg of Lycium barbarum or Lycium chinense berries paste, 30 liters of water are added. The treatment cycle is thus started once the vacuum has been achieved for a period of 2 hours at a constant internal temperature of 40 ° C. At the end of the treatment cycle, the puree thus obtained is taken up and subjected to filtration in a candle filter at a pressure of 6 bar allowing particles to pass between 10 and 50 microns. The resulting filtrate, pinkish in color and having a viscosity of 101 Pa at 20 ° C., is suddenly cooled to 4 ° C. in order to preserve the organoleptic properties of the components. The jelly obtained is reserved as well as the cake. The jelly thus contains all the soluble molecules extracted from the berries Lycium barbarum or Lycium chinense as well as the vegetable particles with a size of 10 to 50 microns.
Selon l'invention les tests nacrés des mollusques bivalves marins sont lavés à l'eau courante, décontaminés à l'aide d'une solution désinfectante composée d'eau déminéralisée additionnée de 2% d'hypochlorique de sodium, puis sont rincés à l'eau courante à une température de 70°C et séchés. Ils sont ensuite concassés dans un concasseur de type FRITSCH jusqu'à l'obtention de particules de 2 à 5 mm broyées dans un planétaire à billes dont le produit est ensuite tamisé dans une tamiseuse dont le diamètre des pores du tamis est de 70 microns. Les microparticules dont traitées dans un tambour en inox tournant sur un axe horizontal, alternativement dans les deux sens, à une vitesse 50 tours/mn pendant une durée de 2 heures. Ce traitement à pour but de donner une forme sphérique aux microparticules en arrondissant les angles et les arêtes par frottement, leur donnant un aspect de microgranules et optimiser leur imprégnation Selon l'invention les microgranules ainsi obtenues sont mélangées au filtrat, sous forme de gelée de baies Lycium barbarum ou de Lycium chinense l'ensemble est placé dans un évapoconcentrateur sous vide. Cette opération a pour but d'imprégner la fraction organique des microgranules ainsi que la fraction minérale, le carbonate de calcium, qui sont toutes deux hydrophiles comme l'indique la teinte rosée des microgranules à la fin du traitement. L'ensemble est ensuite séché sous courant d'air à une température de 40°C et réservé. Selon l'invention le gâteau résultant de la filtration dans le filtre à bougie est séché puis mélangé aux microgranules imprégnées de la gelée de baies de Lycium barbarum ou de Lycium chilense. L'ensemble est broyé dans un broyeur à mortier jusqu'à l'obtention d'une poudre homogène. According to the invention the pearlescent tests of marine bivalve molluscs are washed with running water, decontaminated with a disinfectant solution composed of demineralised water with 2% of sodium hypochloric, and then rinsed with water. running water at a temperature of 70 ° C and dried. They are then crushed in a FRITSCH type crusher until obtaining particles of 2 to 5 mm ground in a planetary ball whose product is then sieved in a sieve with a sieve pore diameter of 70 microns. The microparticles treated in a stainless steel drum rotating on a horizontal axis, alternately in both directions, at a speed of 50 rpm for a period of 2 hours. This treatment is intended to give the microparticles a spherical shape by rounding the angles and edges by friction, giving them a microgranule appearance and optimizing their impregnation. According to the invention, the microgranules thus obtained are mixed with the filtrate, in the form of a jelly. berries Lycium barbarum or Lycium chinense the whole is placed in a vacuum evapoconcentrator. This operation is intended to impregnate the organic fraction of the microgranules and the mineral fraction, calcium carbonate, which are both hydrophilic as indicated by the pinkish tint of the microgranules at the end of the treatment. The whole is then dried under a stream of air at a temperature of 40 ° C and reserved. According to the invention, the cake resulting from the filtration in the candle filter is dried and then mixed with microgranules impregnated with Lycium barbarum or Lycium chilense berries jelly. The whole is ground in a mortar grinder until a homogeneous powder is obtained.
Selon un mode de réalisation préférentiel, le produit selon l'invention peut être associé à d'autres substances telles : la spiruline, l'acérola, la poudre de quinoa, de guarana, poudre de feuille maté, de thé vert, la caféine, le gingembre, des probiotiques tels que lactobacillus plantarum, lactobacillus acidophylus bifido bacterium, des composés vitaminiques organiques, le curcuma ou toutes autres substances biologiques toutes les fois où on désire lui conférer des propriétés spécifiques.According to a preferred embodiment, the product according to the invention can be combined with other substances such as: spirulina, acerola, quinoa powder, guarana powder, mate leaf powder, green tea, caffeine, ginger, probiotics such as lactobacillus plantarum, lactobacillus acidophyllus bifido bacterium, organic vitamin compounds, turmeric or any other biological substance whenever it is desired to confer specific properties.
3 C'est ainsi que le produit selon l'invention entre dans la composition de gélules, de capsules, de comprimés, de tablettes, de gels, de solutions aqueuses, de granulés. Les exemples suivants illustrent les différentes compositions possibles du produit selon l'invention. Exemple 1 : pour une gélule de 300 mg - Microgranules enrobés 200 mg Poudre d'acérola 50 mg Poudre de spiruline 25 mg - Caféine 25 m Exemple II : Le produit selon l'invention est associé à des extraits de Muira puama ou de Richeria grandis préparés selon la méthode suivante : 10 kg de racines de Muira puama ou d'écorce de Richeria grandis sont mis à macérer dans un récipient en acier inox d'une contenance de 30 litres, rempli de 20 litres d'alcool éthylique à 90°, le tout hermétiquement clos, pendant 8 jours, de manière à avoir une alcoolature simple d'extraction des composants . Le produit ainsi obtenu, est filtré et placé dans un dispositif à évaporation rotatif du type Rotavapor, destiné à condenser sous vide l'alcoolature afin de ne pas dénaturer les principes actifs. En effet l'alcoolature est placé par batch dans un ballon en verre d'une contenance de 4 litres, plongé dans un récipient contenant de l'eau chauffée à 60°C, le système de refroidissement du dispositif est parcouru par de l'eau maintenue à une température constante de 20°C avec un débit de 40 litres/heure, pour une vapeur produite à 40° C, le ballon tournant à 50tours/min. Après 3 heures on obtient un condensat de couleur brunâtre qui est lyophilisé et mélangé aux microgranules enrobés pour une gélule de 300mg selon la formule suivante. Microgranules enrobés 200 mg Poudre d'acérola 50mg Lyophilisat de Muira puama 20mg Poudre de thé vert 30mg Exemple 3 : Microgranules enrobés 200mg 4 Lyophilisat de Richeria grandis 50mg Curcuma 25mg Poudre de panax ginseng 25mg. Exemple 4 : - Microgranules enrobés 200 mg 50mg Poudre d'acérola Lactobacilus plantarum 15 mg - Lactobacilus acidophylus 20 mg - Bifido bacterium 15 mg Exemple 5 : - Microgranules enrobés 200 mg Poudre d'acérola 50mg Guarana 25 mg Spiruline 25 mg 20 5 Thus the product according to the invention is included in the composition of capsules, capsules, tablets, lozenges, gels, aqueous solutions, granules. The following examples illustrate the different possible compositions of the product according to the invention. Example 1: for a 300 mg capsule - coated microgranules 200 mg Acerola powder 50 mg Spirulina powder 25 mg - Caffeine 25 m Example II: The product according to the invention is combined with extracts of Muira puama or Richeria grandis prepared according to the following method: 10 kg of Muira puama roots or of Richeria grandis bark are macerated in a 30-liter stainless steel container, filled with 20 liters of 90 ° ethyl alcohol, the whole hermetically closed for 8 days, so as to have a simple alcoholic component extraction. The product thus obtained is filtered and placed in a rotating evaporator device of the Rotavapor type, intended to condense the alcohol in a vacuum so as not to denature the active ingredients. In fact the alcohol is placed batchwise in a glass flask of a capacity of 4 liters, immersed in a container containing water heated to 60 ° C, the cooling system of the device is traversed by water maintained at a constant temperature of 20 ° C with a flow rate of 40 liters / hour, for a steam produced at 40 ° C, the balloon rotating at 50rpm. After 3 hours, a brownish condensate is obtained which is lyophilized and mixed with the coated microgranules for a 300 mg capsule according to the following formula. Coated microgranules 200 mg Acerola powder 50mg Muira puama lyophilisate 20mg Green tea powder 30mg Example 3: Microgranules coated 200mg 4 Lyophilisate Richeria grandis 50mg Turmeric 25mg Powder panax ginseng 25mg. Example 4: Coated microgranules 200 mg 50 mg Acerola powder Lactobacilus plantarum 15 mg Lactobacilus acidophylus 20 mg Bifido bacterium 15 mg Example 5 Microgranules coated 200 mg Acerola powder 50 mg Guarana 25 mg Spirulina 25 mg 5
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1004775A FR2968169B1 (en) | 2010-12-06 | 2010-12-06 | FOOD SUPPLEMENT, FIELD MODIFIER COMPRISING THE MARINE ARAGONITE MICROGRANULES COATED WITH A LYCIUM BARBARUM OR CHINENSE BERRY BOWL |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1004775A FR2968169B1 (en) | 2010-12-06 | 2010-12-06 | FOOD SUPPLEMENT, FIELD MODIFIER COMPRISING THE MARINE ARAGONITE MICROGRANULES COATED WITH A LYCIUM BARBARUM OR CHINENSE BERRY BOWL |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2968169A1 true FR2968169A1 (en) | 2012-06-08 |
| FR2968169B1 FR2968169B1 (en) | 2014-01-10 |
Family
ID=44119491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1004775A Expired - Fee Related FR2968169B1 (en) | 2010-12-06 | 2010-12-06 | FOOD SUPPLEMENT, FIELD MODIFIER COMPRISING THE MARINE ARAGONITE MICROGRANULES COATED WITH A LYCIUM BARBARUM OR CHINENSE BERRY BOWL |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2968169B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109900532A (en) * | 2019-01-10 | 2019-06-18 | 青海省农林科学院 | Fructus lycii pre-treating method when a kind of measurement dry fruit fructus lycii stable isotope |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001084963A1 (en) * | 2000-05-11 | 2001-11-15 | Pharma Futura | Edible composition containing micronised nacre powder |
| US6503541B1 (en) * | 1999-06-10 | 2003-01-07 | Pacific Corporation | Method for preparation of plant extract powder oral compositions containing plant extract powder prepared by the same |
| US20090104290A1 (en) * | 2007-10-05 | 2009-04-23 | David Rowland | Energizing formulation |
| CN101564163A (en) * | 2009-02-25 | 2009-10-28 | 田向东 | Food for reducing blood sugar and blood fat and preparation method thereof |
| FR2953103A1 (en) * | 2009-11-30 | 2011-06-03 | Camprasse Steeve Harold | Metabolism modifying nutritional supplement, useful in the formulation of e.g. gel capsules, tablets, lozenges, gels, and granules, comprises powder of Lycium barbarum and Lycium chinense berry coating microgranules of marine aragonite |
-
2010
- 2010-12-06 FR FR1004775A patent/FR2968169B1/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6503541B1 (en) * | 1999-06-10 | 2003-01-07 | Pacific Corporation | Method for preparation of plant extract powder oral compositions containing plant extract powder prepared by the same |
| WO2001084963A1 (en) * | 2000-05-11 | 2001-11-15 | Pharma Futura | Edible composition containing micronised nacre powder |
| US20090104290A1 (en) * | 2007-10-05 | 2009-04-23 | David Rowland | Energizing formulation |
| CN101564163A (en) * | 2009-02-25 | 2009-10-28 | 田向东 | Food for reducing blood sugar and blood fat and preparation method thereof |
| FR2953103A1 (en) * | 2009-11-30 | 2011-06-03 | Camprasse Steeve Harold | Metabolism modifying nutritional supplement, useful in the formulation of e.g. gel capsules, tablets, lozenges, gels, and granules, comprises powder of Lycium barbarum and Lycium chinense berry coating microgranules of marine aragonite |
Non-Patent Citations (3)
| Title |
|---|
| ANONYMOUS: "Finding Herbal Alternatives to bear bile", INTERNET CITATION, 1 January 2006 (2006-01-01), pages 1 - 66, XP002588593, Retrieved from the Internet <URL:http://www.wspa-usa.org/download/144_findingherbalalternativestobearb ilev3.pdf> [retrieved on 20100623] * |
| DATABASE WPI Week 200975, Derwent World Patents Index; AN 2009-Q94280, XP002647701 * |
| GRANT VINNING: "Medicinal herbs: A compendium", INTERNET CITATION, 1 August 2004 (2004-08-01), pages 1 - 13, XP002588594, Retrieved from the Internet <URL:http://www.trade.gov.bt/administration/mktbriefs/10.pdf> [retrieved on 20100623] * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109900532A (en) * | 2019-01-10 | 2019-06-18 | 青海省农林科学院 | Fructus lycii pre-treating method when a kind of measurement dry fruit fructus lycii stable isotope |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2968169B1 (en) | 2014-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3285784B1 (en) | Method for preparing a fecal microbiota sample | |
| US10980842B2 (en) | Composition for promotng bone formation with fermented oysters and seaweed | |
| CN104922171B (en) | Use of red quinoa extract for preparing compositions for promoting collagen production and anti-aging skin | |
| CN110946196B (en) | Mujiang Yeke granules and preparation method thereof | |
| KR20160058389A (en) | Method of Manufacturing Volumizing Antocyanine Probiotics Metabolite and Pharmetics, cosmetics and Juice and food complex | |
| WO2009008656A2 (en) | A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof | |
| AU2019304599A1 (en) | Microbiological process for the production of bee bread | |
| RU2366435C1 (en) | Method for making preparation of natural honey for treatment of various diseases (versions) | |
| TW201210633A (en) | Agent for promoting hyaluronic acid production | |
| KR101670649B1 (en) | A method for preparation of mixed composition with fermented medical plants extracts | |
| EP2651422B1 (en) | Compositions comprising clay and beepollen, method of preparation and therapeutical or nutritional uses thereof | |
| FR2968169A1 (en) | Biological response modifying nutritional supplement, comprises marine aragonite microgranules coated with a freeze-dried jelly of Lycium barbarum or Lycium chinense berry | |
| WO2012007670A2 (en) | Cosmetic or dermatological composition and use thereof for caring for the skin of young men | |
| JP2012158536A (en) | Antidepressant | |
| KR101067648B1 (en) | Preparation and Functionality of Kelp Concentrate Containing Chlorophyll | |
| JP2003169621A (en) | Tea of momordica charantia and method for producing the same | |
| TW201713353A (en) | Caulerpa lentillifera extract and flavonoid extraction method thereof | |
| FR2953103A1 (en) | Metabolism modifying nutritional supplement, useful in the formulation of e.g. gel capsules, tablets, lozenges, gels, and granules, comprises powder of Lycium barbarum and Lycium chinense berry coating microgranules of marine aragonite | |
| KR102217456B1 (en) | Fermenting method for honey using microorganism, fermented honey manufactured by the same and products using thereof | |
| FR3132436A1 (en) | METHOD FOR OBTAINING PLANT EXTRACTS COMPRISING A SELF-FERMENTATION STEP, COMPOSITIONS COMPRISING SUCH EXTRACTS AND THEIR COSMETIC USES | |
| KR102270221B1 (en) | Antifungal composition containing citrus grandis osbeck and rubus coreanus miquel complex | |
| TW201132291A (en) | Immunostimulant having allium-derived component, method for producing immunostimulant, food composition, and immunostimulatory method | |
| CN111433217A (en) | Extraction method of wasabi extract | |
| KR102389839B1 (en) | Health supplement composition for improving bronchial function including natural extracts | |
| KR20100070154A (en) | Anti-diabetic composition comprising essentially of chlorella hot extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| PLFP | Fee payment |
Year of fee payment: 7 |
|
| PLFP | Fee payment |
Year of fee payment: 8 |
|
| CA | Change of address |
Effective date: 20180709 |
|
| ST | Notification of lapse |
Effective date: 20190905 |